4.7 Editorial Material

MOTOR TICS, STEREOTYPIES, AND SELF-FLAGELLATION IN PRIMROSE SYNDROME

Journal

NEUROLOGY
Volume 75, Issue 3, Pages 284-286

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3181e8e754

Keywords

-

Funding

  1. NCI NIH HHS [P50 CA116201-5, R01CA 104132-5, U24CA 74800-11] Funding Source: Medline
  2. NIMH NIH HHS [R01 MH08185, R01 MH078160] Funding Source: Medline
  3. NINDS NIH HHS [NS056276] Funding Source: Medline
  4. NCBDD CDC HHS [18DD00344] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Clinical Neurology

Teaching NeuroImages: The dentate sign in subacute cerebellar ataxia Metronidazole neurotoxicity

Merida Teran Jimenez, Philippe Salles Gandara, Alberto J. Espay

NEUROLOGY (2023)

Article Neurosciences

From urges to tics in children with Tourette syndrome: associations with supplementary motor area GABA and right motor cortex physiology

Travis R. Larsh, David A. Huddleston, Paul S. Horn, Steve W. Wu, Kim M. Cecil, Hannah S. Jackson, Richard A. E. Edden, Stewart H. Mostofsky, Donald L. Gilbert

Summary: Tourette syndrome (TS) is a childhood-onset disorder characterized by tics preceded by premonitory sensory urges. This study found that the intensity of the urges strongly correlated with tic severity. More severe urges were associated with lower cortical excitability (CE) and weaker cortical inhibition in both right and left M1. Interestingly, in the right M1, lower CE and weaker inhibition correlated with less severe tics. The study suggests that in young children with TS, the reduction of CE and inhibition in the right M1, modulated by the supplementary motor area (SMA) and gamma-amino butyric acid (GABA), may serve as compensatory mechanisms to diminish tics in response to premonitory urges.

CEREBRAL CORTEX (2023)

Article Clinical Neurology

The spectrum of functional tic-like behaviours: Data from an international registry

Davide Martino, Tammy Hedderly, Tara Murphy, Kirsten R. Mueller-Vahl, Russell C. Dale, Donald L. Gilbert, Renata Rizzo, Andreas Hartmann, Peter Nagy, Mathieu Anheim, Tamsin Owen, Osman Malik, Morvwen Duncan, Isobel Heyman, Holan Liang, Andrew McWilliams, Shauna O'Dwyer, Carolin Fremer, Natalia Szejko, Velda X. Han, Kasia Kozlowska, Tamara M. Pringsheim

Summary: There has been a significant increase in adolescents and young adults seeking urgent help for functional tic-like behaviors (FTLBs) between 2019 and 2022. An international collaborative group collected retrospective data to better understand this spectrum and its clinical differences from primary tic disorders. The study findings suggest that social media exposure may be a relevant contributing factor to FTLBs.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Bradykinesia in Neurodegenerative Disorders: A Blinded Video Analysis of Pathology-Proven Cases

Luca Marsili, Kevin R. Duque, Nathan Gregor, Elhusseini Abdelghany, Jesus Abanto, Andrew P. Duker, Matthew C. Hagen, Alberto J. Espay, Matteo Bologna

Summary: This study found no significant differences in the features of bradykinesia between patients with synucleinopathies and tauopathies.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders

Alonso Zea Vera, Adrienne Bruce, Travis R. Larsh, Zachary Jordan, Norbert Bruggemann, Ana Westenberger, Alberto J. Espay, Donald L. Gilbert, Steve W. Wu

Summary: POLR3A-related disorders exhibit significant phenotypic pleomorphism, including a range of movement disorders such as parkinsonism, dystonia, ataxia, and spasticity. Vertical gaze dysfunction and T2-weighted/FLAIR hyperintensity of the superior cerebellar peduncles and midbrain may be useful signs suggestive of this condition.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Biomarkers of tic severity in children with Tourette syndrome: Motor cortex inhibition measured with transcranial magnetic stimulation

Mitchell A. Batschelett, David A. Huddleston, Deana Crocetti, Paul S. Horn, Stewart H. Mostofsky, Donald L. Gilbert

Summary: This study compared transcranial magnetic stimulation (TMS)-derived measures of primary motor cortex (M1) physiology between children with and without Tourette syndrome, and found that reduced M1 short-interval cortical inhibition (SICI) is associated with increased tic severity, but not urge severity.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2023)

Article Clinical Neurology

Adolescent Gender Differences in Tic- and Non-Tic-Related Impairments in Tourette Syndrome

Travis R. Larsh, Steve W. W. Wu, David A. Huddleston, Sean White, Tara D. Lipps, Donald L. Gilbert

Summary: This study aimed to compare tic- and non-tic-related impairment experienced by adolescent boys and girls with Tourette syndrome, and its association with age. Data from electronic health records and questionnaires were analyzed for 132 unique adolescent encounters. The findings suggest that tic- and non-tic-related impairment may improve with age in boys but not in girls, and that obsessive-compulsive symptoms are associated with non-tic-related impairment in girls. Further longitudinal studies are needed to confirm these findings.

JOURNAL OF CHILD NEUROLOGY (2023)

Article Clinical Neurology

Redefining Bradykinesia

Matteo Bologna, Alberto J. Espay, Alfonso Fasano, Giulia Paparella, Mark Hallett, Alfredo Berardelli

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Differences in Tic Severity Among Adolescent Girls and Boys with Tourette Syndrome During the Pandemic

Travis R. Larsh, Steve W. Wu, David A. Huddleston, Tara D. Lipps, Donald L. Gilbert

Summary: This study aimed to compare sex differences in tic severity among adolescents with Tourette syndrome (TS) before and during the COVID-19 pandemic. The study found that during the pandemic, boys had less severe tics compared to girls, while there were no significant differences in tic severity between boys and girls before the pandemic.

NEUROPEDIATRICS (2023)

Editorial Material Clinical Neurology

Alpha-synuclein and the Parkinson's disease drug pipeline

Alberto J. Espay, Kevin McFarthing

Summary: The process of protein aggregation involves the transformation of soluble peptides into insoluble cross-beta amyloids. In Parkinson's disease, soluble monomeric a-synuclein transforms into the amyloid state known as Lewy pathology. Most disease-modifying projects in the therapeutic pipeline for Parkinson's disease aim to reduce the insoluble a-synuclein fraction, while none aim to increase soluble a-synuclein levels. We propose rebalancing the therapeutic pipeline to include treatments that restore soluble a-synuclein within a normal range.

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

Motor Function and Physiology in Youth With Neurofibromatosis Type 1

Alexander C. Doherty, David A. Huddleston, Paul S. Horn, Nancy Ratner, Brittany N. Simpson, Elizabeth K. Schorry, Lindsey Aschbacher-Smith, Carlos E. Prada, Donald L. Gilbert

Summary: Neurofibromatosis type 1 (NF1) is a genetic disorder with motor and cognitive symptoms that severely impact quality of life. This study used transcranial magnetic stimulation (TMS) to assess motor cortex physiology in children with NF1, ADHD, and typically developing (TD) children. It was found that children with NF1 had impaired motor function and altered motor cortex physiology compared to TD and ADHD children.

PEDIATRIC NEUROLOGY (2023)

Article Clinical Neurology

Digital Biomarkers in Parkinson's Disease: Missing the Forest for the Trees?

Ashwani Jha, Alberto J. Espay, Andrew J. Lees

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study

Alberto J. Espay, Robert A. Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Leonid Zeitlin, Ghazal Banisadr, Stanley Fisher, Hester Visser

Summary: In this open-label extension of a phase 3 study, IPX203 demonstrated a favorable safety profile and sustained efficacy similar to the double-blind study. Improvements in efficacy were maintained throughout the trial, and adverse events were mostly mild or moderate and occurred within the first 90 days of treatment.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP)

Vindhya Koneru, Alberto J. Espay, Allan J. Cole, Daniel Weintraub, Kathleen Crist, Maria B. Pascual, William G. Ondo

MOVEMENT DISORDERS (2023)

No Data Available